Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Oma-CR + Oma-DR
- Development stage
- Unknown
- Lead developer
- Rangs Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Oma-CR and Oma-DR are brand names for formulations of omeprazole manufactured and marketed by Rangs Pharmaceuticals. Omeprazole is a proton pump inhibitor (PPI) that suppresses gastric acid secretion by specific inhibition of the H+/K+-ATPase enzyme system at the secretory surface of the gastric parietal cell. By covalently binding to this enzyme, it blocks the final step of acid production, effectively reducing gastric acidity. Oma-CR likely refers to a controlled-release formulation, while Oma-DR refers to a delayed-release formulation, both designed to manage acid-related gastrointestinal disorders such as gastroesophageal reflux disease (GERD), peptic ulcer disease, and hypersecretory conditions like Zollinger-Ellison syndrome.
- Other names
- omeprazole
02
Targets
ATP4A (Potassium–transporting ATPase alpha chain 1)
Beyond the preview
Go deeper on Oma-CR + Oma-DR.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Oma-CR + Oma-DR.